RevMedica is empowering surgeons with objective, actionable insight before, during, and after stapler deployment – recommending the correct size reload, adjusting deployment speed, and providing real-time compression guidance.
Improper reload selection and lack of adequate tissue intelligence have been directly linked to staple line complications and serious injuries – outcomes that are costly for patients and hospitals.¹
RevMedica is turning insight into action to empower surgeons with greater clarity, confidence, and data to support more informed decisions.
The next generation of surgical stapling is challenging convention with a deeper understanding, real-time insight, and technologies that augment surgeon experience.
RevMedica unites engineers, clinical experts, industry leaders, and surgeon advisors to challenge convention and shape this surgical stapling future.
RevMedica collaborates with surgeons, healthcare providers, and technology partners to advance surgical stapling beyond what can be seen.
Interested in learning more?
Mike joined RevMedica in November 2026, bringing over 30 years of global medical technology leadership experience in commercialization, innovation, and business growth.
Prior to joining RevMedica, Mike spent 30 years at Boston Scientific, most recently serving as Senior Vice President and President of its approximately $3 billion Endoscopy division. In this role, he led global operations, R&D, and commercial strategy across more than 175 countries, delivering sustained revenue growth, expanding market share, and advancing innovation through strategic acquisitions and partnerships.
Mike also serves as a Board Director and strategic advisor to emerging medical technology companies and private equity investors.
At RevMedica, Mike leads corporate strategy, organizational growth, and commercialization efforts as the company works to bring intelligent surgical stapling technology to market.
Mike holds a Bachelor of Science in Accounting from Colorado State University.